Fig. 2From: Objective evaluation of chemotherapy-induced peripheral neuropathy using quantitative pain measurement system (Pain Vision®), a pilot studyThe CONSORT diagram of the study patients. Indicated the CONSORT diagram of the study patients. Fifty-seven patients agreed to the participation in the study period. Forty-one patients who were able to continue chemotherapy were analyzedBack to article page